Combo Tx Promising in Non-Clear Cell Renal Carcinoma (CME/CE)

(MedPage Today) -- ' Compelling ' results from Zortress-Avastin phase II trial
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news